EARS - Auris Medical Holding Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.85M
Enterprise Value 38.85M
Trailing P/E N/A
Forward P/E 1-0.77
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.19
52-Week Change 3-51.43%
S&P500 52-Week Change 30.90%
52 Week High 339.4000
52 Week Low 32.4100
50-Day Moving Average 32.7187
200-Day Moving Average 34.7582

Share Statistics

Avg Vol (3 month) 3188.07k
Avg Vol (10 day) 396.66k
Shares Outstanding 5N/A
Float 2.66M
% Held by Insiders 116.57%
% Held by Institutions 14.68%
Shares Short (Jul 31, 2019) 4173.59k
Short Ratio (Jul 31, 2019) 41.9
Short % of Float (Jul 31, 2019) 411.10%
Short % of Shares Outstanding (Jul 31, 2019) 47.77%
Shares Short (prior month Jun 28, 2019) 4205.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3May 1, 2019

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-49.77%
Return on Equity (ttm)-380.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-1.3270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.54
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A